Clinical trial designs for the approval of rare cancer drugs in Japan

被引：0
|
作者：
Noguchi, E. [1 ]
Yonemori, K. [1 ]
Shimoi, T. [1 ]
Yunokawa, M. [1 ]
Okuma, H. S. [2 ]
Kawachi, A. [2 ]
Kitano, A. [3 ]
Nishikawa, T. [2 ]
Shimomura, A. [2 ]
Shimizu, C. [2 ]
Takiguchi, Y. [4 ]
Kawai, A. [5 ]
Fujiwara, Y. [2 ]
Tamura, K. [2 ]
机构：
[1] Natl Canc Ctr, Rare Canc Ctr, Breast & Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Breast & Med Oncol, Tokyo, Japan
[3] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan
[4] Chiba Univ, Grad Sch Med, Med Oncol, Chiba, Japan
[5] Natl Canc Ctr, Rare Canc Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
154P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs
    Similon, Miriam von Mucke
    Paasche, Cecilia
    Krol, Fas
    Lerer, Bernard
    Goodwin, Guy M.
    Berk, Michael
    Meyer-Lindenberg, Andreas
    Ketter, Terence A.
    Yatham, Lakshmi N.
    Goldberg, Joseph F.
    Malhi, Gin S.
    El-Mallakh, Rif
    Licht, Rasmus W.
    Young, Allan H.
    Kapczinski, Flavio
    Swartz, Marnina
    Hagin, Michal
    Torrent, Carla
    Serretti, Alessandro
    Yildiz, Aysegul
    Martinez-Aran, Anabel
    Strejilevich, Sergio
    Rybakowski, Janusz
    Sani, Gabriele
    Grunze, Heinz
    Vazquez, Gustavo
    Pinto, Ana Gonzales
    Azorin, Jean Michel
    Nolen, Willem
    Sentissi, Othman
    Lopez-Jaramillo, Carlos
    Frey, Benicio N.
    Nierenberg, Andrew
    Parker, Gordon
    Bond, David J.
    Cohen, Adam
    Tortorella, Alfonso
    Perugi, Giulio
    Vieta, Eduard
    Popovic, Dina
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 60 : 91 - 99
  • [42] Alternative clinical trial designs
    Harvin, John A.
    Zarzaur, Ben L.
    Nirula, Raminder
    King, Benjamin T.
    Malhotra, Ajai K.
    TRAUMA SURGERY & ACUTE CARE OPEN, 2020, 5 (01)
  • [43] CANCER DRUGS SECURE SPEEDY APPROVAL IN CANADA
    VOGT, C
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (21) : 1620 - 1622
  • [44] Factorial Clinical Trial Designs
    Ciolino, Jody D.
    Scholtens, Denise M.
    Bonner, Lauren B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (06): : 532 - 533
  • [45] Adaptive Clinical Trial Designs
    Papadimitrakopoulou, Vassiliki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S140 - S142
  • [46] PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan
    Matsumura, Noriomi
    Mandai, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (05) : 493 - 494
  • [47] Basket study Yields Approval for Rare Cancer
    Dolgin, Elie
    CANCER DISCOVERY, 2018, 8 (01) : 4 - 4
  • [48] Bayesian cancer clinical trial designs with subgroup-specific decisions
    Thall, Peter F.
    CONTEMPORARY CLINICAL TRIALS, 2020, 90
  • [49] Clinical trial designs for predictive marker validation in cancer treatment trials
    Sargent, DJ
    Conley, BA
    Allegro, C
    Collette, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 2020 - 2027
  • [50] Novel clinical trial designs emerging from the molecular reclassification of cancer
    Nikanjam, Mina
    Kato, Shumei
    Allen, Teresa
    Sicklick, Jason K.
    Kurzrock, Razelle
    CA-A CANCER JOURNAL FOR CLINICIANS, 2025,
12345